Literature DB >> 31270046

[Long noncoding RNA UFC1 promotes metastasis and invasion of hepatocellular carcinoma cells in vitro via GSK-3β/β-catenin axis].

Jian Wang1, Chuanhui Cao1, Qin Zeng1, Zhongyi Dong1.   

Abstract

OBJECTIVE: To explore the role of Long noncoding RNA UFC1 (lincRNA-UFC1) in modulating the metastasis and invasion of hepatocellular carcinoma (HCC) cells and the underlying mechanism.
METHODS: Human HCC cell line Huh7 was infected with the lentiviral vector carrying lincRNA-UFC1 to obtain a cell line with lincRNA-UFC1 overexpression. A short hairpin RNA (shRNA) targeting lincRNA-UFC1 was delivered in human HCC BEL-7402 cells via a lentiviral vector to obtain a cell line with lincRNA-UFC1 knockdown. Expression levels of lincRNA-UFC1 in the two HCC cell lines were detected using real-time PCR, and the changes in the cell invasion and migration in response to lincRNA-UFC1 overexpression or knockdown were analyzed using Transwell and wound-healing assays. The expressions of GSK-3β/β-catenin-related proteins in the cells were detected with Western blotting. XAV-939, a GSK-3β/β-catenin inhibitor, was used for assessing the impact of lincRNAUFC1 overexpression on the invasion and migration of the HCC cells through Transwell and wound-healing assays.
RESULTS: Overexpression of lincRNA-UFC1 significantly promoted the invasion and migration of Huh7 cells as compared with the control cells (P < 0.001), while lincRNA-UFC1 knockdown obviously suppressed the invasion and migration of BEL-7402 cells (P < 0.001). The results of Western blotting showed that the expressions of proteins associated with the cell invasion and migration, namely β-catenin and P-GSK-3β, were significantly upregulated in response to lincRNA-UFC1 overexpression, and were obviously lowered after lincRNA-UFC1 knockdown. Treatment of the cells with XAV-939 significantly reversed the effect of lincRNA-UFC1 overexpression on the cell invasion and migration (P < 0.001).
CONCLUSIONS: lincRNA-UFC1 overexpresison promotes cell invasion and migration through the GSK-3β/β-catenin axis in HCC cells in vitro.

Entities:  

Keywords:  hepatocellular carcinoma; lincRNA-UFC1; p-GSK3; tumor progression; β-catenin

Mesh:

Substances:

Year:  2019        PMID: 31270046      PMCID: PMC6743920          DOI: 10.12122/j.issn.1673-4254.2019.06.08

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  29 in total

1.  Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.

Authors:  Shamar Young; Paul Craig; Jafar Golzarian
Journal:  Eur Radiol       Date:  2018-10-22       Impact factor: 5.315

2.  HuR and translation--the missing linc(RNA).

Authors:  Carol J Wilusz; Jeffrey Wilusz
Journal:  Mol Cell       Date:  2012-08-24       Impact factor: 17.970

3.  Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.

Authors:  Sheng-Xian Yuan; Fu Yang; Yuan Yang; Qi-Fei Tao; Jin Zhang; Gang Huang; Yun Yang; Ruo-Yu Wang; Sen Yang; Xi-Song Huo; Ling Zhang; Fang Wang; Shu-Han Sun; Wei-Ping Zhou
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

4.  The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489.

Authors:  Kun Wang; Fang Liu; Lu-Yu Zhou; Bo Long; Shu-Min Yuan; Yin Wang; Cui-Yun Liu; Teng Sun; Xiao-Jie Zhang; Pei-Feng Li
Journal:  Circ Res       Date:  2014-02-20       Impact factor: 17.367

5.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

6.  Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.

Authors:  Li Wang; Hongying Zhao; Yingqi Xu; Jing Li; Chunyu Deng; Yulan Deng; Jing Bai; Xia Li; Yun Xiao; Yunpeng Zhang
Journal:  Int J Cancer       Date:  2018-12-12       Impact factor: 7.396

7.  Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression.

Authors:  John R Prensner; Matthew K Iyer; O Alejandro Balbin; Saravana M Dhanasekaran; Qi Cao; J Chad Brenner; Bharathi Laxman; Irfan A Asangani; Catherine S Grasso; Hal D Kominsky; Xuhong Cao; Xiaojun Jing; Xiaoju Wang; Javed Siddiqui; John T Wei; Daniel Robinson; Hari K Iyer; Nallasivam Palanisamy; Christopher A Maher; Arul M Chinnaiyan
Journal:  Nat Biotechnol       Date:  2011-07-31       Impact factor: 54.908

8.  lncRNA FEZF1-AS1 Is Associated With Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion.

Authors:  Zhenjun Liu; Pei Zhao; Yuping Han; Song Lu
Journal:  Oncol Res       Date:  2018-03-06       Impact factor: 5.574

9.  Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers.

Authors:  Y Takahashi; G Sawada; J Kurashige; R Uchi; T Matsumura; H Ueo; Y Takano; H Eguchi; T Sudo; K Sugimachi; H Yamamoto; Y Doki; M Mori; K Mimori
Journal:  Br J Cancer       Date:  2013-11-05       Impact factor: 7.640

10.  Knockdown of linc-UFC1 suppresses proliferation and induces apoptosis of colorectal cancer.

Authors:  T Yu; T-D Shan; J-Y Li; C-Z Huang; S-Y Wang; H Ouyang; X-J Lu; J-H Xu; W Zhong; Q-K Chen
Journal:  Cell Death Dis       Date:  2016-05-19       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.